Syngene biologics manufacturing facility to be operational for US and European customers from mid-year

Posted on by

New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day BANGALORE, India, March 14, 2024 /PRNewswire/ — At DCAT 2024 global bio/pharmaceutical manufacturing forum, Syngene International, a global…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.